High-resolution genomic analysis in Waldenström's macroglobulinemia identifies disease-specific and common abnormalities with marginal zone lymphomas

Esteban D Braggio, Jonathan Keats, Xavier Leleu, Scott Van Wier, Victor Hugo Jimenez-Zepeda, Roelandt Schop, Marta Chesi, Michael Barrett, Alexander Keith Stewart, Ahmet Dogan, Peter Leif Bergsagel, Irene Ghobrial, Rafael Fonseca

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Cytogenetic analyses have been historically limited in Waldenström's macroglobulinemia (WM) by the difficulty to obtain tumor metaphases. Thus, few recurrent karyotypic abnormalities have been reported and the molecular consequences of these imbalances are largely unknown. We used an array-based comparative genomic hybridization approach to better characterize the recurrent chromosome abnormalities associated with WM pathogenesis and to compare them with the publicly available findings in other B-cell neoplasias. The majority of the recurrent chromosome abnormalities identified in WM were shared with marginal zone lymphomas (MZL), as deletions of 6q23 and 13q14 and gains of 3q13-q28, 6p and 18q. On the other hand, gains of 4q and 8q were recurrently identified in WM but have not been described as being common abnormalities in MZL. The genetic consequences of these specific abnormalities remain elusive and further studies are critical to refine the search and to precise the molecular pathways affected by these abnormalities.

Original languageEnglish (US)
Pages (from-to)39-42
Number of pages4
JournalClinical Lymphoma and Myeloma
Volume9
Issue number1
DOIs
StatePublished - 2009

Fingerprint

Waldenstrom Macroglobulinemia
Lymphoma
Chromosome Aberrations
Comparative Genomic Hybridization
Cytogenetic Analysis
Metaphase
Neoplasms
B-Lymphocytes

Keywords

  • ACGH
  • Comparative genomic analysis
  • Waldenström

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Hematology

Cite this

High-resolution genomic analysis in Waldenström's macroglobulinemia identifies disease-specific and common abnormalities with marginal zone lymphomas. / Braggio, Esteban D; Keats, Jonathan; Leleu, Xavier; Wier, Scott Van; Jimenez-Zepeda, Victor Hugo; Schop, Roelandt; Chesi, Marta; Barrett, Michael; Stewart, Alexander Keith; Dogan, Ahmet; Bergsagel, Peter Leif; Ghobrial, Irene; Fonseca, Rafael.

In: Clinical Lymphoma and Myeloma, Vol. 9, No. 1, 2009, p. 39-42.

Research output: Contribution to journalArticle

@article{0478d315ea2f4a5993964b4c3fe50269,
title = "High-resolution genomic analysis in Waldenstr{\"o}m's macroglobulinemia identifies disease-specific and common abnormalities with marginal zone lymphomas",
abstract = "Cytogenetic analyses have been historically limited in Waldenstr{\"o}m's macroglobulinemia (WM) by the difficulty to obtain tumor metaphases. Thus, few recurrent karyotypic abnormalities have been reported and the molecular consequences of these imbalances are largely unknown. We used an array-based comparative genomic hybridization approach to better characterize the recurrent chromosome abnormalities associated with WM pathogenesis and to compare them with the publicly available findings in other B-cell neoplasias. The majority of the recurrent chromosome abnormalities identified in WM were shared with marginal zone lymphomas (MZL), as deletions of 6q23 and 13q14 and gains of 3q13-q28, 6p and 18q. On the other hand, gains of 4q and 8q were recurrently identified in WM but have not been described as being common abnormalities in MZL. The genetic consequences of these specific abnormalities remain elusive and further studies are critical to refine the search and to precise the molecular pathways affected by these abnormalities.",
keywords = "ACGH, Comparative genomic analysis, Waldenstr{\"o}m",
author = "Braggio, {Esteban D} and Jonathan Keats and Xavier Leleu and Wier, {Scott Van} and Jimenez-Zepeda, {Victor Hugo} and Roelandt Schop and Marta Chesi and Michael Barrett and Stewart, {Alexander Keith} and Ahmet Dogan and Bergsagel, {Peter Leif} and Irene Ghobrial and Rafael Fonseca",
year = "2009",
doi = "10.3816/CLM.2009.n.009",
language = "English (US)",
volume = "9",
pages = "39--42",
journal = "Clinical Lymphoma, Myeloma and Leukemia",
issn = "2152-2669",
publisher = "Cancer Media Group",
number = "1",

}

TY - JOUR

T1 - High-resolution genomic analysis in Waldenström's macroglobulinemia identifies disease-specific and common abnormalities with marginal zone lymphomas

AU - Braggio, Esteban D

AU - Keats, Jonathan

AU - Leleu, Xavier

AU - Wier, Scott Van

AU - Jimenez-Zepeda, Victor Hugo

AU - Schop, Roelandt

AU - Chesi, Marta

AU - Barrett, Michael

AU - Stewart, Alexander Keith

AU - Dogan, Ahmet

AU - Bergsagel, Peter Leif

AU - Ghobrial, Irene

AU - Fonseca, Rafael

PY - 2009

Y1 - 2009

N2 - Cytogenetic analyses have been historically limited in Waldenström's macroglobulinemia (WM) by the difficulty to obtain tumor metaphases. Thus, few recurrent karyotypic abnormalities have been reported and the molecular consequences of these imbalances are largely unknown. We used an array-based comparative genomic hybridization approach to better characterize the recurrent chromosome abnormalities associated with WM pathogenesis and to compare them with the publicly available findings in other B-cell neoplasias. The majority of the recurrent chromosome abnormalities identified in WM were shared with marginal zone lymphomas (MZL), as deletions of 6q23 and 13q14 and gains of 3q13-q28, 6p and 18q. On the other hand, gains of 4q and 8q were recurrently identified in WM but have not been described as being common abnormalities in MZL. The genetic consequences of these specific abnormalities remain elusive and further studies are critical to refine the search and to precise the molecular pathways affected by these abnormalities.

AB - Cytogenetic analyses have been historically limited in Waldenström's macroglobulinemia (WM) by the difficulty to obtain tumor metaphases. Thus, few recurrent karyotypic abnormalities have been reported and the molecular consequences of these imbalances are largely unknown. We used an array-based comparative genomic hybridization approach to better characterize the recurrent chromosome abnormalities associated with WM pathogenesis and to compare them with the publicly available findings in other B-cell neoplasias. The majority of the recurrent chromosome abnormalities identified in WM were shared with marginal zone lymphomas (MZL), as deletions of 6q23 and 13q14 and gains of 3q13-q28, 6p and 18q. On the other hand, gains of 4q and 8q were recurrently identified in WM but have not been described as being common abnormalities in MZL. The genetic consequences of these specific abnormalities remain elusive and further studies are critical to refine the search and to precise the molecular pathways affected by these abnormalities.

KW - ACGH

KW - Comparative genomic analysis

KW - Waldenström

UR - http://www.scopus.com/inward/record.url?scp=67649510148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649510148&partnerID=8YFLogxK

U2 - 10.3816/CLM.2009.n.009

DO - 10.3816/CLM.2009.n.009

M3 - Article

VL - 9

SP - 39

EP - 42

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

SN - 2152-2669

IS - 1

ER -